Medication-related osteonecrosis of the jaw in osteoporotic patients receiving antiresorptive therapy: prevalence and associated risk factors.

Kumbara F, Eser F

Open source

DOI
10.1007/s11657-026-01769-8
Published
2026 Aug 26
Container
Archives of osteoporosis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11657-026-01769-8,
  title = {Medication-related osteonecrosis of the jaw in osteoporotic patients receiving antiresorptive therapy: prevalence and associated risk factors.},
  author = {Kumbara F and Eser F},
  year = {2026},
  journal = {Archives of osteoporosis},
  doi = {10.1007/s11657-026-01769-8},
  url = {https://doi.org/10.1007/s11657-026-01769-8}
}

RIS

TY  - JOUR
TI  - Medication-related osteonecrosis of the jaw in osteoporotic patients receiving antiresorptive therapy: prevalence and associated risk factors.
AU  - Kumbara F
AU  - Eser F
PY  - 2026
JO  - Archives of osteoporosis
DO  - 10.1007/s11657-026-01769-8
UR  - https://doi.org/10.1007/s11657-026-01769-8
ER  - 

APA

F, K., & F, E. (2026). Medication-related osteonecrosis of the jaw in osteoporotic patients receiving antiresorptive therapy: prevalence and associated risk factors.. Archives of osteoporosis. https://doi.org/10.1007/s11657-026-01769-8

Source records